Longevity Medicine
What Is Alzheimer's Prevention?
Last reviewed: May 2026 · Haute MD Editorial Team
Alzheimer's prevention is the systematic reduction of modifiable risk factors that the 2024 Lancet Commission estimates account for ~45% of dementia risk. Although age and APOE genotype are not modifiable, intervention on cardiovascular, sleep, hearing, social, and metabolic factors substantially reduces lifetime risk and is the foundation of brain-health longevity care.
What's modifiable
The 2024 Lancet Commission identifies 14 modifiable risk factors accounting for 45% of dementia risk: less education in early life, hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol, traumatic brain injury, air pollution, social isolation, untreated vision loss, and high LDL cholesterol. Cardiovascular factors in midlife dominate — hypertension between 40 and 65 is the single largest modifiable contributor. Untreated hearing loss accounts for ~8% of risk and is among the most undertreated. Sleep is not included in the Lancet list but observational evidence is consistent with meaningful impact, particularly from untreated sleep apnea and chronic short sleep. Aggressive control of these factors in midlife appears most impactful — pathology begins 15-20 years before symptoms.
Evidence-based prevention strategies
(1) Control blood pressure to <130/80 in midlife — the SPRINT-MIND trial demonstrated reduced MCI incidence with aggressive BP control; (2) Treat hearing loss with hearing aids — ACHIEVE trial showed slowed cognitive decline in high-risk older adults using hearing aids; (3) Structured aerobic exercise 150+ min/week plus resistance training 2x/week — among the most robust interventions, with direct effects on brain volume and BDNF; (4) Mediterranean or MIND diet patterns; (5) Treat sleep apnea aggressively; (6) Maintain social engagement; (7) Cognitive engagement throughout life — formal education early, ongoing learning later; (8) Limit alcohol to ≤7 drinks/week; (9) Eliminate tobacco; (10) Control diabetes — HbA1c <7%; (11) Treat depression; (12) Wear helmets in high-risk activities; (13) Minimize anticholinergic medication use, particularly long-term. The FINGER trial (multidomain lifestyle intervention) and ongoing US-POINTER trial provide the strongest evidence that combined intervention preserves cognition in at-risk older adults.
How to build a prevention program
(1) Establish baseline cognitive testing in midlife; (2) Comprehensive cardiovascular risk assessment — BP, lipids, glucose/HbA1c, ApoB, Lp(a); (3) Hearing screen at 50 and serially thereafter; (4) Sleep evaluation including consideration of home sleep apnea testing; (5) APOE genotype if interested — knowing carrier status increases motivation for aggressive prevention in many patients, though counseling is recommended; (6) Structured exercise program with both aerobic and resistance components; (7) Mediterranean dietary pattern; (8) Maintain social engagement and cognitive challenge; (9) Annual or biennial cognitive reassessment to track trajectory; (10) For APOE4 carriers and those with family history, consider plasma p-tau217 or amyloid PET surveillance starting at 55-60 to identify preclinical Alzheimer's pathology when therapeutic windows are widest. Prevention is most effective started in midlife but yields measurable benefit even when started in the 60s and 70s.
Frequently Asked Questions
What's the single most important Alzheimer's prevention strategy?
Hard to rank one — but midlife blood pressure control, regular structured exercise, treating hearing loss, and treating sleep apnea are among the highest-yield single interventions. Combined multidomain intervention (FINGER trial design) outperforms any single change.
Does the Mediterranean diet really prevent dementia?
Observational and trial evidence is consistent with modest reduction in cognitive decline. The MIND diet (a hybrid of Mediterranean and DASH) has slightly stronger evidence in some cohorts. Effect sizes are real but moderate; diet alone is unlikely to be sufficient.
If I have an APOE4 allele, can I still prevent Alzheimer's?
Yes — APOE4 increases risk but is not deterministic. Carriers benefit more in absolute terms from prevention than non-carriers. Many APOE4 carriers never develop Alzheimer's, and many non-carriers do. Aggressive cardiovascular, sleep, exercise, and lifestyle intervention is particularly valuable.
Are 'brain games' effective for prevention?
Modestly. Training on specific tasks improves performance on those tasks; transfer to general cognitive function is limited. Education, ongoing complex learning, and social engagement appear more impactful than commercial brain-training apps.
Get Help Now
Speak with a Haute MD Longevity Medicine physician
Dr. George Kaltner
CEO
Longevity Medicine · Miami Beach, FL
View Profile
Dr. Alexander Golberg
Longevity Medicine · New York, NY
View Profile
Dr. Steven Victor
Regenerative Medicine Specialist
Longevity Medicine · New York, NY
View ProfileAre you a Longevity Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · LONGEVITY MEDICINE
What Is MCI (Mild Cognitive Impairment)?
Mild cognitive impairment (MCI) is measurable cognitive decline beyond normal aging without functional disability — a key window for intervention.
Read GuideGuide · LONGEVITY MEDICINE
What Is Cognitive Reserve?
Cognitive reserve is the brain's capacity to tolerate pathology before symptoms appear — built by education, occupation, and lifelong cognitive engagement.
Read GuideGuide · LONGEVITY MEDICINE
What Is the APOE Gene?
APOE genotype is the strongest common genetic risk factor for Alzheimer's disease. Learn what e4, e3, and e2 alleles mean for cognitive longevity.
Read Guide